Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: 60 Degrees, Adlai Nortye, Advaccine, Akeso, Apeiron, Arcturus, Ascletis, Astellas, Astrazeneca, Gan & Lee, I-Mab, Inflarx, Inovio, Medigen Vaccine Biologics, Neurobo, Oncolytics, RDIF, Reistone, Resverlogix, TC Biopharm, Westvac.